Related Experiment Video
Updated: Dec 23, 2025
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.3K
Community pharmacist workflow: Space for Pharmacy-based Interventions and Consultation TimE study protocol
Ajay Mahendrarai Karia1, Christine Balane2, Richard Norman1
1School of Public Health, Faculty of Health Sciences, Curtin University, Perth, WA, Australia.
The International Journal of Pharmacy Practice
|April 30, 2020
Summary
This study used time and motion methods to assess Australian pharmacists
Area of Science:
- Pharmacy Practice Research
- Health Services Research
- Workforce Capacity Studies
Background:
- Pharmacists' roles are expanding to include medication management, vaccinations, and screening.
- Limited research exists on Australian community pharmacists' capacity for expanded services.
- This study protocol addresses this gap by investigating workload capacity.
Purpose of the Study:
- To investigate the variation in pharmacists' daily tasks and workspace.
- To measure workload capacity for expanding pharmacy services in Australian community pharmacies.
- To provide quantitative evidence on pharmacists' time and work setting.
Main Methods:
- Observational time and motion study in up to 20 Australian community pharmacies.
- Data collection using the electronic Work Observation Method By Activity Timing (WOMBAT) tool.
- Analysis of task duration, multitasking, interruptions, and workspace environment, including heat-mapped floor plans.
Main Results:
- This section is not available in the provided abstract.
- This section is not available in the provided abstract.
- This section is not available in the provided abstract.
Conclusions:
- Pharmacists can potentially alleviate strained health systems.
- Novel time and motion methodology will enhance understanding of Australian community pharmacy practice.
- Findings will inform pharmacists' capacity and optimize their work environment.
More Related Videos
10:38Observational Study Protocol for Repeated Clinical Examination and Critical Care Ultrasonography Within the Simple Intensive Care Studies
Published on: January 16, 2019
20.7K
08:59An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
Published on: December 3, 2020
8.4K
Related Concept Videos
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
95
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
95
01:28Dosage Regimens: Designs and Approaches
185
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
185
01:20Chronopharmacokinetics: Time-Dependent Pharmacokinetics
344
Chronopharmacokinetics studies the temporal change in drug absorption and elimination. These changes can be cyclical or non-cyclical. Cyclical changes occur over a regular interval, while non-cyclical changes occur over a longer, irregular period.
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
Time-dependent pharmacokinetics refers to non-cyclical changes in drug rate processes over a period of time. It can lead to nonlinear pharmacokinetics, where the relationship between drug concentration and time is not proportional. Non-cyclical...
344
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
285
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
285
01:30Community Based Intervention
226
Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
226
01:12Analysis of Population Pharmacokinetic Data
606
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
606